Pancreatic Cancer Research

ResearcherFirst Hospital of China Medical UniversityActive in the last 2 years

Chunlin Ge

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6727-0596; OpenAlex author ID A5101817084. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2015: 1 paper · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 5

  1. Prevalence and Impact of Frailty in Pancreatic Cancer: A Systematic Review and Meta-Analysis Based on 35,191 Patients. Last author DOI 10.1245/s10434-023-14426-y↗
  2. Mapping Intellectual Structure and Research Performance for the Nanoparticles in Pancreatic Cancer Field. Last author DOI 10.2147/ijn.s253599↗
  3. Gene expression profile analysis of pancreatic cancer based on microarray data. Last author DOI 10.3892/mmr.2016.5021↗
  4. Identification of genes and pathways associated with pancreatic ductal adenocarcinoma by bioinformatics analyses. Last author DOI 10.3892/ol.2015.4042↗
  5. microRNA-218 promotes gemcitabine sensitivity in human pancreatic cancer cells by regulating HMGB1 expression. Co-author DOI 10.3978/j.issn.1000-9604.2015.04.06↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fei Zhang · 1 shared paper, 2024 · strength 0.36
  2. Jin Long · 3 shared papers, 2015–2016 · strength 0.21
  3. Yuanhong Xu · 3 shared papers, 2015–2016 · strength 0.21
  4. Xuan Zhu · 1 shared paper, 2020 · strength 0.15
  5. Zhe Liu · 2 shared papers, 2015–2016 · strength 0.13
  6. Xingda Wu · 1 shared paper, 2016 · strength 0.08
  7. Zhe Liu · 1 shared paper, 2016 · strength 0.08
  8. Zhongbo Zhang · 1 shared paper, 2016 · strength 0.08
  9. Ruixia Du · 1 shared paper, 2015 · strength 0.06
  10. Kejian Guo · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.